Regencell Bioscience Holdings Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.1% | +3.7% | +0.5% | +7.5% | -100.0% | +111.3% | -33.8% | +5,197.6% | -30.0% | -33.1% | -31.8% | |
| – | -26.6% | +28.4% | +2.0% | +3.7% | -99.9% | +59.0% | -82.7% | +24,499.6% | -29.3% | -30.2% | -39.6% | |
| – | -47.6% | +49.3% | +12.2% | -7.2% | -99.9% | +59.0% | -84.6% | +10,700.7% | -75.6% | +89.2% | -18.3% | |
| – | -47.6% | +45.5% | +12.2% | -7.2% | -99.9% | +59.0% | -84.6% | +27,532.0% | -29.6% | -31.2% | -38.5% | |
| – | – | – | +1.3% | +18.6% | – | – | – | +271.1% | +104.9% | +170.2% | – | |
| – | -6.3% | +25.8% | -6.7% | +9.6% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -24.4% | +1,683.4% | – | – | – | |
| – | +0.0% | +2.6% | -0.5% | +5.7% | – | – | – | – | – | – | – | |
| – | -6.6% | -6.9% | -8.4% | -5.2% | – | – | – | – | – | – | – | |
| – | +0.5% | +2.2% | -0.7% | +6.1% | -99.9% | +52.0% | +37.1% | -78.4% | -32.6% | -65.3% | +307.9% | |
| – | -5.8% | +15.6% | -7.5% | +10.1% | -99.6% | +52.0% | +37.1% | -86.7% | +5.0% | -68.1% | +242.8% | |
| – | -10.7% | +3.0% | -6.9% | +4.3% | -92.2% | +47.5% | +19.9% | -88.8% | +6.6% | -86.4% | +423.0% | |
| – | -2.6% | +38.6% | -15.2% | +19.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -29.5% | -31.7% | -40.9% | |
| – | -32.6% | +32.6% | +50.3% | -26.5% | -102.6% | – | – | – | – | – | – | |
| – | +0.4% | +0.1% | +0.2% | +0.1% | -91.9% | +0.0% | +0.0% | +2.9% | +0.0% | +0.0% | +0.0% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.